These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene. Derkay CS; Grundfast KM Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251 [TBL] [Abstract][Full Text] [Related]
8. Anesthesia in malignant hyperthermia susceptible patients. Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553 [TBL] [Abstract][Full Text] [Related]
9. [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living]. Jacquot C; Stieglitz P Ann Fr Anesth Reanim; 1989; 8(5):417-26. PubMed ID: 2697156 [TBL] [Abstract][Full Text] [Related]
11. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824 [TBL] [Abstract][Full Text] [Related]
12. [Malignant hyperthermia in Austria. III. Anesthesia in susceptible patients]. Mauritz W; Hackl W; Sporn P; Steinbereithner K Anaesthesist; 1988 Aug; 37(8):522-8. PubMed ID: 3177878 [TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update. Patil PM Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956 [TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia. Rosenberg H; Davis M; James D; Pollock N; Stowell K Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235 [TBL] [Abstract][Full Text] [Related]
15. [Clinical features of malignant hyperthermia crisis]. Cornet C; Moeller R; Laxenaire MC Ann Fr Anesth Reanim; 1989; 8(5):435-43. PubMed ID: 2516711 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family. Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662 [TBL] [Abstract][Full Text] [Related]
17. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility. Allen GC; Rosenberg H; Fletcher JE Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777 [TBL] [Abstract][Full Text] [Related]
18. Malignant Hyperthermia Susceptibility and Fitness for Duty. Lee MA; McGlinch EB; McGlinch MC; Capacchione JF Mil Med; 2017 Mar; 182(3):e1854-e1857. PubMed ID: 28290972 [TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia. Ben Abraham R; Adnet P; Glauber V; Perel A Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480 [TBL] [Abstract][Full Text] [Related]
20. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis. O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]